Stephanie J Cheng, NP
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Stephanie J Cheng’s office at (650) 691-6174 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$10,582
Medicare paid this office $10,582 for 103 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 42 | $3,993 | $81 |
| Short return visit (20+ min) | 46 | $2,842 | $58 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
103 Original Medicare patients in 2024. Average age 75 · Women 65% · Also on Medicaid 17% · Health risk score 0.96. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 58% · Diabetes 23% · Coronary heart disease 18% · Chronic kidney disease 17% · Depression 16% · Cancer 12%.
The office billed $42,377, Medicare allowed $15,871 and paid $10,582; for 139 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 103 | 139 | 75 | 0.96 | $42,377 | $10,582 |
| 2023 | 139 | 194 | 76 | 0.81 | $55,188 | $15,979 |
| 2022 | 102 | 141 | 75 | 0.81 | $36,418 | $10,807 |
| 2021 | 123 | 215 | 76 | 0.88 | $46,840 | $15,701 |
| 2020 | 80 | 132 | 74 | 0.90 | $25,168 | $7,118 |
| 2019 | 108 | 201 | 73 | 0.95 | $377,765 | $12,145 |
| 2018 | 81 | 144 | 72 | 0.92 | $81,096 | $7,956 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 69 | $7,139 | $89 |
| Short return visit (20+ min) | 52 | $3,250 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,763 | $136 |
2022: 2 services
| Short return visit (20+ min) | 59 | $4,463 | $69 |
| Return visit (30+ min) | 33 | $3,163 | $85 |
2021: 3 services
| Short return visit (20+ min) | 72 | $5,421 | $65 |
| Return visit (30+ min) | 38 | $5,254 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,192 | $137 |
2020: 2 services
| Short return visit (20+ min) | 33 | $1,894 | $57 |
| Return visit (30+ min) | 23 | $1,554 | $62 |
2019: 2 services
| Return visit (30+ min) | 51 | $4,154 | $77 |
| Short return visit (20+ min) | 14 | $858 | $54 |
2018: 2 services
| Return visit (30+ min) | 33 | $2,162 | $64 |
| Short return visit (20+ min) | 22 | $1,120 | $47 |
Drugs they prescribed that Part D paid
$17,048
Pharmacies billed $17,048 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
342 generic and fewer than 11 brand-name prescriptions · $17,048 in drug cost · 27 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lisinopril | 21 | $241 | $11 |
| Omeprazole | 12 | $159 | $13 |
| Sertraline | 20 | $154 | $8 |
| Atorvastatin | 24 | $109 | $5 |
| Losartan | 15 | $103 | $7 |
See all 8 drugs
| Lisinopril | 21 | $241 | $11 |
| Omeprazole | 12 | $159 | $13 |
| Sertraline | 20 | $154 | $8 |
| Atorvastatin | 24 | $109 | $5 |
| Losartan | 15 | $103 | $7 |
| Fluticasone Propionate | 13 | $89 | $7 |
| Levothyroxine | 11 | $72 | $7 |
| Metformin | 14 | $35 | $3 |
Year by year
| 2024 | 370 | 119 | None | None | $17,048 |
| 2023 | 287 | 122 | None | 9% | $18,984 |
| 2022 | 299 | 120 | None | None | $12,323 |
| 2021 | 294 | 136 | 4% (11) | 11% | $20,433 |
| 2020 | 455 | 151 | None | 13% | $25,958 |
| 2019 | 725 | 262 | 3% (23) | 14% | $32,537 |
| 2018 | 285 | 130 | 11% (30) | 17% | $11,752 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Losartan | 11 | $207 | $19 |
| Paxlovid (Eua) | 11 | $121 | $11 |
| Sertraline | 13 | $105 | $8 |
| Metformin | 12 | $70 | $6 |
2022: 5 drugs
| Levothyroxine | 14 | $462 | $33 |
| Amlodipine Besylate | 22 | $135 | $6 |
| Atorvastatin | 11 | $130 | $12 |
| Lisinopril | 14 | $92 | $7 |
| Metformin | 11 | $69 | $6 |
2021: 5 drugs
| Levothyroxine | 14 | $450 | $32 |
| Atorvastatin | 12 | $335 | $28 |
| Amlodipine Besylate | 16 | $234 | $15 |
| Metformin | 15 | $174 | $12 |
| Simvastatin | 13 | $131 | $10 |
2020: 10 drugs
| Levothyroxine | 24 | $638 | $27 |
| Metoprolol | 15 | $597 | $40 |
| Atorvastatin | 39 | $596 | $15 |
| Metformin | 30 | $295 | $10 |
| Simvastatin | 22 | $284 | $13 |
| Lisinopril | 23 | $185 | $8 |
| Hydrochlorothiazide | 11 | $123 | $11 |
| Omeprazole | 16 | $122 | $8 |
| Amlodipine Besylate | 20 | $117 | $6 |
| Sertraline | 11 | $111 | $10 |
2019: 14 drugs
| Levothyroxine | 41 | $961 | $23 |
| Atorvastatin | 66 | $885 | $13 |
| Proair Hfa | 13 | $805 | $62 |
| Metformin | 37 | $296 | $8 |
| Amlodipine Besylate | 23 | $271 | $12 |
| Lisinopril | 37 | $252 | $7 |
| Losartan | 25 | $213 | $9 |
| Sertraline | 13 | $202 | $16 |
| Simvastatin | 21 | $186 | $9 |
| Hydrochlorothiazide | 17 | $162 | $10 |
| Azithromycin | 17 | $161 | $9 |
| Atenolol | 13 | $131 | $10 |
| Naproxen | 20 | $89 | $4 |
| Metoprolol | 19 | $88 | $5 |
2018: 7 drugs
| Hydrocodone-Acetaminophen | 19 | $395 | $21 |
| Atorvastatin | 14 | $211 | $15 |
| Metoprolol | 11 | $200 | $18 |
| Amlodipine Besylate | 17 | $159 | $9 |
| Losartan | 12 | $102 | $9 |
| Simvastatin | 11 | $81 | $7 |
| Lisinopril | 12 | $66 | $6 |
Money from drug and device companies
$125 in 2025
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Rexulti | $125 | 1 payment
|
See the published payment
| Otsuka America Pharmaceutical | Meals · 2025-06-18 | Rexulti | $125 |
Professional record
- NPI
- 1679086847
- Licence
- CA 95007919
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-11-09
- NPI last updated
- 2020-02-12
- NPI record certified
- 2020-02-12
This is when the NPI record was last certified, not a medical board exam.